 | • レポートコード：MRC2-11QY12811 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、181ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はユビキチン酵素のグローバル市場について調査・分析したレポートです。種類別（E1ユビキチン活性化酵素、ビキチン結合酵素、E3ユビキチンリガーゼ）市場規模、用途別（がん、生物工学、消化器病学、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ユビキチン酵素の競争状況、市場シェア ・世界のユビキチン酵素市場：種類別市場規模 2015年-2020年（E1ユビキチン活性化酵素、ビキチン結合酵素、E3ユビキチンリガーゼ） ・世界のユビキチン酵素市場：種類別市場規模予測 2021年-2026年（E1ユビキチン活性化酵素、ビキチン結合酵素、E3ユビキチンリガーゼ） ・世界のユビキチン酵素市場：用途別市場規模 2015年-2020年（がん、生物工学、消化器病学、その他） ・世界のユビキチン酵素市場：用途別市場規模予測 2021年-2026年（がん、生物工学、消化器病学、その他） ・北米のユビキチン酵素市場分析：米国、カナダ ・ヨーロッパのユビキチン酵素市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのユビキチン酵素市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のユビキチン酵素市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのユビキチン酵素市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：3SBio、5AM Ventures、Abbiotec、Abcam、AcelRx Pharmaceuticals、Aegera Therapeutics、Aeneas Ventures、Agilis Biotherapeutics、Aileron Therapeutics、Aju IB Investment、Alexion Pharmaceuticals、Almac Discovery、Amgen、Angelman Syndrome Foundation、Apeiron Biologics、Boston Biochem、BPS Biosciences、Business Development Bank of Canada、C4 Therapeutics、Calculus Capital、Canaan Partners、Cancer Research Technology、Captor Therapeutics、Carmot Therapeutics、Cayman Chemicals、Celgene Corporation、Cell Signaling Technology ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Ubiquitin Enzymes Market
The global Ubiquitin Enzymes market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Ubiquitin Enzymes Scope and Market Size
Ubiquitin Enzymes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ubiquitin Enzymes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Ubiquitin Enzymes market is segmented into
E1 Ubiquitin Activating Enzyme
E2 Ubiquitin Crosslinking Enzyme
E3 Ubiquitin Ligase
Segment by Application, the Ubiquitin Enzymes market is segmented into
Cancer
Biological Engineering
Gastroenterology
Others
Regional and Country-level Analysis
The Ubiquitin Enzymes market is analysed and market size information is provided by regions (countries).
The key regions covered in the Ubiquitin Enzymes market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Ubiquitin Enzymes Market Share Analysis
Ubiquitin Enzymes market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ubiquitin Enzymes business, the date to enter into the Ubiquitin Enzymes market, Ubiquitin Enzymes product introduction, recent developments, etc.
The major vendors covered:
3SBio
5AM Ventures
Abbiotec
Abcam
AcelRx Pharmaceuticals
Aegera Therapeutics
Aeneas Ventures
Agilis Biotherapeutics
Aileron Therapeutics
Aju IB Investment
Alexion Pharmaceuticals
Almac Discovery
Amgen
Angelman Syndrome Foundation
Apeiron Biologics
Boston Biochem
BPS Biosciences
Business Development Bank of Canada
C4 Therapeutics
Calculus Capital
Canaan Partners
Cancer Research Technology
Captor Therapeutics
Carmot Therapeutics
Cayman Chemicals
Celgene Corporation
Cell Signaling Technology
1 Study Coverage
1.1 Ubiquitin Enzymes Product Introduction
1.2 Market Segments
1.3 Key Ubiquitin Enzymes Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Ubiquitin Enzymes Market Size Growth Rate by Type
1.4.2 E1 Ubiquitin Activating Enzyme
1.4.3 E2 Ubiquitin Crosslinking Enzyme
1.4.4 E3 Ubiquitin Ligase
1.5 Market by Application
1.5.1 Global Ubiquitin Enzymes Market Size Growth Rate by Application
1.5.2 Cancer
1.5.3 Biological Engineering
1.5.4 Gastroenterology
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Ubiquitin Enzymes Market Size, Estimates and Forecasts
2.1.1 Global Ubiquitin Enzymes Revenue 2015-2026
2.1.2 Global Ubiquitin Enzymes Sales 2015-2026
2.2 Global Ubiquitin Enzymes, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Ubiquitin Enzymes Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Ubiquitin Enzymes Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Ubiquitin Enzymes Competitor Landscape by Players
3.1 Ubiquitin Enzymes Sales by Manufacturers
3.1.1 Ubiquitin Enzymes Sales by Manufacturers (2015-2020)
3.1.2 Ubiquitin Enzymes Sales Market Share by Manufacturers (2015-2020)
3.2 Ubiquitin Enzymes Revenue by Manufacturers
3.2.1 Ubiquitin Enzymes Revenue by Manufacturers (2015-2020)
3.2.2 Ubiquitin Enzymes Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Ubiquitin Enzymes Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Ubiquitin Enzymes Revenue in 2019
3.2.5 Global Ubiquitin Enzymes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Ubiquitin Enzymes Price by Manufacturers
3.4 Ubiquitin Enzymes Manufacturing Base Distribution, Product Types
3.4.1 Ubiquitin Enzymes Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ubiquitin Enzymes Product Type
3.4.3 Date of International Manufacturers Enter into Ubiquitin Enzymes Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Ubiquitin Enzymes Market Size by Type (2015-2020)
4.1.1 Global Ubiquitin Enzymes Sales by Type (2015-2020)
4.1.2 Global Ubiquitin Enzymes Revenue by Type (2015-2020)
4.1.3 Ubiquitin Enzymes Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Ubiquitin Enzymes Market Size Forecast by Type (2021-2026)
4.2.1 Global Ubiquitin Enzymes Sales Forecast by Type (2021-2026)
4.2.2 Global Ubiquitin Enzymes Revenue Forecast by Type (2021-2026)
4.2.3 Ubiquitin Enzymes Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Ubiquitin Enzymes Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Ubiquitin Enzymes Market Size by Application (2015-2020)
5.1.1 Global Ubiquitin Enzymes Sales by Application (2015-2020)
5.1.2 Global Ubiquitin Enzymes Revenue by Application (2015-2020)
5.1.3 Ubiquitin Enzymes Price by Application (2015-2020)
5.2 Ubiquitin Enzymes Market Size Forecast by Application (2021-2026)
5.2.1 Global Ubiquitin Enzymes Sales Forecast by Application (2021-2026)
5.2.2 Global Ubiquitin Enzymes Revenue Forecast by Application (2021-2026)
5.2.3 Global Ubiquitin Enzymes Price Forecast by Application (2021-2026)
6 North America
6.1 North America Ubiquitin Enzymes by Country
6.1.1 North America Ubiquitin Enzymes Sales by Country
6.1.2 North America Ubiquitin Enzymes Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Ubiquitin Enzymes Market Facts & Figures by Type
6.3 North America Ubiquitin Enzymes Market Facts & Figures by Application
7 Europe
7.1 Europe Ubiquitin Enzymes by Country
7.1.1 Europe Ubiquitin Enzymes Sales by Country
7.1.2 Europe Ubiquitin Enzymes Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Ubiquitin Enzymes Market Facts & Figures by Type
7.3 Europe Ubiquitin Enzymes Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Ubiquitin Enzymes by Region
8.1.1 Asia Pacific Ubiquitin Enzymes Sales by Region
8.1.2 Asia Pacific Ubiquitin Enzymes Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Ubiquitin Enzymes Market Facts & Figures by Type
8.3 Asia Pacific Ubiquitin Enzymes Market Facts & Figures by Application
9 Latin America
9.1 Latin America Ubiquitin Enzymes by Country
9.1.1 Latin America Ubiquitin Enzymes Sales by Country
9.1.2 Latin America Ubiquitin Enzymes Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Ubiquitin Enzymes Market Facts & Figures by Type
9.3 Central & South America Ubiquitin Enzymes Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Ubiquitin Enzymes by Country
10.1.1 Middle East and Africa Ubiquitin Enzymes Sales by Country
10.1.2 Middle East and Africa Ubiquitin Enzymes Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Ubiquitin Enzymes Market Facts & Figures by Type
10.3 Middle East and Africa Ubiquitin Enzymes Market Facts & Figures by Application
11 Company Profiles
11.1 3SBio
11.1.1 3SBio Corporation Information
11.1.2 3SBio Description and Business Overview
11.1.3 3SBio Sales, Revenue and Gross Margin (2015-2020)
11.1.4 3SBio Ubiquitin Enzymes Products Offered
11.1.5 3SBio Related Developments
11.2 5AM Ventures
11.2.1 5AM Ventures Corporation Information
11.2.2 5AM Ventures Description and Business Overview
11.2.3 5AM Ventures Sales, Revenue and Gross Margin (2015-2020)
11.2.4 5AM Ventures Ubiquitin Enzymes Products Offered
11.2.5 5AM Ventures Related Developments
11.3 Abbiotec
11.3.1 Abbiotec Corporation Information
11.3.2 Abbiotec Description and Business Overview
11.3.3 Abbiotec Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Abbiotec Ubiquitin Enzymes Products Offered
11.3.5 Abbiotec Related Developments
11.4 Abcam
11.4.1 Abcam Corporation Information
11.4.2 Abcam Description and Business Overview
11.4.3 Abcam Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Abcam Ubiquitin Enzymes Products Offered
11.4.5 Abcam Related Developments
11.5 AcelRx Pharmaceuticals
11.5.1 AcelRx Pharmaceuticals Corporation Information
11.5.2 AcelRx Pharmaceuticals Description and Business Overview
11.5.3 AcelRx Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AcelRx Pharmaceuticals Ubiquitin Enzymes Products Offered
11.5.5 AcelRx Pharmaceuticals Related Developments
11.6 Aegera Therapeutics
11.6.1 Aegera Therapeutics Corporation Information
11.6.2 Aegera Therapeutics Description and Business Overview
11.6.3 Aegera Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Aegera Therapeutics Ubiquitin Enzymes Products Offered
11.6.5 Aegera Therapeutics Related Developments
11.7 Aeneas Ventures
11.7.1 Aeneas Ventures Corporation Information
11.7.2 Aeneas Ventures Description and Business Overview
11.7.3 Aeneas Ventures Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Aeneas Ventures Ubiquitin Enzymes Products Offered
11.7.5 Aeneas Ventures Related Developments
11.8 Agilis Biotherapeutics
11.8.1 Agilis Biotherapeutics Corporation Information
11.8.2 Agilis Biotherapeutics Description and Business Overview
11.8.3 Agilis Biotherapeutics Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Agilis Biotherapeutics Ubiquitin Enzymes Products Offered
11.8.5 Agilis Biotherapeutics Related Developments
11.9 Aileron Therapeutics
11.9.1 Aileron Therapeutics Corporation Information
11.9.2 Aileron Therapeutics Description and Business Overview
11.9.3 Aileron Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Aileron Therapeutics Ubiquitin Enzymes Products Offered
11.9.5 Aileron Therapeutics Related Developments
11.10 Aju IB Investment
11.10.1 Aju IB Investment Corporation Information
11.10.2 Aju IB Investment Description and Business Overview
11.10.3 Aju IB Investment Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Aju IB Investment Ubiquitin Enzymes Products Offered
11.10.5 Aju IB Investment Related Developments
11.1 3SBio
11.1.1 3SBio Corporation Information
11.1.2 3SBio Description and Business Overview
11.1.3 3SBio Sales, Revenue and Gross Margin (2015-2020)
11.1.4 3SBio Ubiquitin Enzymes Products Offered
11.1.5 3SBio Related Developments
11.12 Almac Discovery
11.12.1 Almac Discovery Corporation Information
11.12.2 Almac Discovery Description and Business Overview
11.12.3 Almac Discovery Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Almac Discovery Products Offered
11.12.5 Almac Discovery Related Developments
11.13 Amgen
11.13.1 Amgen Corporation Information
11.13.2 Amgen Description and Business Overview
11.13.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Amgen Products Offered
11.13.5 Amgen Related Developments
11.14 Angelman Syndrome Foundation
11.14.1 Angelman Syndrome Foundation Corporation Information
11.14.2 Angelman Syndrome Foundation Description and Business Overview
11.14.3 Angelman Syndrome Foundation Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Angelman Syndrome Foundation Products Offered
11.14.5 Angelman Syndrome Foundation Related Developments
11.15 Apeiron Biologics
11.15.1 Apeiron Biologics Corporation Information
11.15.2 Apeiron Biologics Description and Business Overview
11.15.3 Apeiron Biologics Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Apeiron Biologics Products Offered
11.15.5 Apeiron Biologics Related Developments
11.16 Boston Biochem
11.16.1 Boston Biochem Corporation Information
11.16.2 Boston Biochem Description and Business Overview
11.16.3 Boston Biochem Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Boston Biochem Products Offered
11.16.5 Boston Biochem Related Developments
11.17 BPS Biosciences
11.17.1 BPS Biosciences Corporation Information
11.17.2 BPS Biosciences Description and Business Overview
11.17.3 BPS Biosciences Sales, Revenue and Gross Margin (2015-2020)
11.17.4 BPS Biosciences Products Offered
11.17.5 BPS Biosciences Related Developments
11.18 Business Development Bank of Canada
11.18.1 Business Development Bank of Canada Corporation Information
11.18.2 Business Development Bank of Canada Description and Business Overview
11.18.3 Business Development Bank of Canada Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Business Development Bank of Canada Products Offered
11.18.5 Business Development Bank of Canada Related Developments
11.19 C4 Therapeutics
11.19.1 C4 Therapeutics Corporation Information
11.19.2 C4 Therapeutics Description and Business Overview
11.19.3 C4 Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.19.4 C4 Therapeutics Products Offered
11.19.5 C4 Therapeutics Related Developments
11.20 Calculus Capital
11.20.1 Calculus Capital Corporation Information
11.20.2 Calculus Capital Description and Business Overview
11.20.3 Calculus Capital Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Calculus Capital Products Offered
11.20.5 Calculus Capital Related Developments
11.21 Canaan Partners
11.21.1 Canaan Partners Corporation Information
11.21.2 Canaan Partners Description and Business Overview
11.21.3 Canaan Partners Sales, Revenue and Gross Margin (2015-2020)
11.21.4 Canaan Partners Products Offered
11.21.5 Canaan Partners Related Developments
11.22 Cancer Research Technology
11.22.1 Cancer Research Technology Corporation Information
11.22.2 Cancer Research Technology Description and Business Overview
11.22.3 Cancer Research Technology Sales, Revenue and Gross Margin (2015-2020)
11.22.4 Cancer Research Technology Products Offered
11.22.5 Cancer Research Technology Related Developments
11.23 Captor Therapeutics
11.23.1 Captor Therapeutics Corporation Information
11.23.2 Captor Therapeutics Description and Business Overview
11.23.3 Captor Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.23.4 Captor Therapeutics Products Offered
11.23.5 Captor Therapeutics Related Developments
11.24 Carmot Therapeutics
11.24.1 Carmot Therapeutics Corporation Information
11.24.2 Carmot Therapeutics Description and Business Overview
11.24.3 Carmot Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.24.4 Carmot Therapeutics Products Offered
11.24.5 Carmot Therapeutics Related Developments
11.25 Cayman Chemicals
11.25.1 Cayman Chemicals Corporation Information
11.25.2 Cayman Chemicals Description and Business Overview
11.25.3 Cayman Chemicals Sales, Revenue and Gross Margin (2015-2020)
11.25.4 Cayman Chemicals Products Offered
11.25.5 Cayman Chemicals Related Developments
11.26 Celgene Corporation
11.26.1 Celgene Corporation Corporation Information
11.26.2 Celgene Corporation Description and Business Overview
11.26.3 Celgene Corporation Sales, Revenue and Gross Margin (2015-2020)
11.26.4 Celgene Corporation Products Offered
11.26.5 Celgene Corporation Related Developments
11.27 Cell Signaling Technology
11.27.1 Cell Signaling Technology Corporation Information
11.27.2 Cell Signaling Technology Description and Business Overview
11.27.3 Cell Signaling Technology Sales, Revenue and Gross Margin (2015-2020)
11.27.4 Cell Signaling Technology Products Offered
11.27.5 Cell Signaling Technology Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Ubiquitin Enzymes Market Estimates and Projections by Region
12.1.1 Global Ubiquitin Enzymes Sales Forecast by Regions 2021-2026
12.1.2 Global Ubiquitin Enzymes Revenue Forecast by Regions 2021-2026
12.2 North America Ubiquitin Enzymes Market Size Forecast (2021-2026)
12.2.1 North America: Ubiquitin Enzymes Sales Forecast (2021-2026)
12.2.2 North America: Ubiquitin Enzymes Revenue Forecast (2021-2026)
12.2.3 North America: Ubiquitin Enzymes Market Size Forecast by Country (2021-2026)
12.3 Europe Ubiquitin Enzymes Market Size Forecast (2021-2026)
12.3.1 Europe: Ubiquitin Enzymes Sales Forecast (2021-2026)
12.3.2 Europe: Ubiquitin Enzymes Revenue Forecast (2021-2026)
12.3.3 Europe: Ubiquitin Enzymes Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Ubiquitin Enzymes Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Ubiquitin Enzymes Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Ubiquitin Enzymes Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Ubiquitin Enzymes Market Size Forecast by Region (2021-2026)
12.5 Latin America Ubiquitin Enzymes Market Size Forecast (2021-2026)
12.5.1 Latin America: Ubiquitin Enzymes Sales Forecast (2021-2026)
12.5.2 Latin America: Ubiquitin Enzymes Revenue Forecast (2021-2026)
12.5.3 Latin America: Ubiquitin Enzymes Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Ubiquitin Enzymes Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Ubiquitin Enzymes Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Ubiquitin Enzymes Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Ubiquitin Enzymes Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Ubiquitin Enzymes Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Ubiquitin Enzymes Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Ubiquitin Enzymes Market Segments
Table 2. Ranking of Global Top Ubiquitin Enzymes Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Ubiquitin Enzymes Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of E1 Ubiquitin Activating Enzyme
Table 5. Major Manufacturers of E2 Ubiquitin Crosslinking Enzyme
Table 6. Major Manufacturers of E3 Ubiquitin Ligase
Table 7. Global Ubiquitin Enzymes Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Ubiquitin Enzymes Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Ubiquitin Enzymes Sales by Regions 2015-2020 (K Units)
Table 10. Global Ubiquitin Enzymes Sales Market Share by Regions (2015-2020)
Table 11. Global Ubiquitin Enzymes Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Ubiquitin Enzymes Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Ubiquitin Enzymes Sales Share by Manufacturers (2015-2020)
Table 14. Global Ubiquitin Enzymes Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Ubiquitin Enzymes by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ubiquitin Enzymes as of 2019)
Table 16. Ubiquitin Enzymes Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Ubiquitin Enzymes Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Ubiquitin Enzymes Price (2015-2020) (USD/Unit)
Table 19. Ubiquitin Enzymes Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Ubiquitin Enzymes Product Type
Table 21. Date of International Manufacturers Enter into Ubiquitin Enzymes Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Ubiquitin Enzymes Sales by Type (2015-2020) (K Units)
Table 24. Global Ubiquitin Enzymes Sales Share by Type (2015-2020)
Table 25. Global Ubiquitin Enzymes Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Ubiquitin Enzymes Revenue Share by Type (2015-2020)
Table 27. Ubiquitin Enzymes Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Ubiquitin Enzymes Sales by Application (2015-2020) (K Units)
Table 29. Global Ubiquitin Enzymes Sales Share by Application (2015-2020)
Table 30. North America Ubiquitin Enzymes Sales by Country (2015-2020) (K Units)
Table 31. North America Ubiquitin Enzymes Sales Market Share by Country (2015-2020)
Table 32. North America Ubiquitin Enzymes Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Ubiquitin Enzymes Revenue Market Share by Country (2015-2020)
Table 34. North America Ubiquitin Enzymes Sales by Type (2015-2020) (K Units)
Table 35. North America Ubiquitin Enzymes Sales Market Share by Type (2015-2020)
Table 36. North America Ubiquitin Enzymes Sales by Application (2015-2020) (K Units)
Table 37. North America Ubiquitin Enzymes Sales Market Share by Application (2015-2020)
Table 38. Europe Ubiquitin Enzymes Sales by Country (2015-2020) (K Units)
Table 39. Europe Ubiquitin Enzymes Sales Market Share by Country (2015-2020)
Table 40. Europe Ubiquitin Enzymes Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Ubiquitin Enzymes Revenue Market Share by Country (2015-2020)
Table 42. Europe Ubiquitin Enzymes Sales by Type (2015-2020) (K Units)
Table 43. Europe Ubiquitin Enzymes Sales Market Share by Type (2015-2020)
Table 44. Europe Ubiquitin Enzymes Sales by Application (2015-2020) (K Units)
Table 45. Europe Ubiquitin Enzymes Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Ubiquitin Enzymes Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Ubiquitin Enzymes Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Ubiquitin Enzymes Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Ubiquitin Enzymes Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Ubiquitin Enzymes Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Ubiquitin Enzymes Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Ubiquitin Enzymes Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Ubiquitin Enzymes Sales Market Share by Application (2015-2020)
Table 54. Latin America Ubiquitin Enzymes Sales by Country (2015-2020) (K Units)
Table 55. Latin America Ubiquitin Enzymes Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Ubiquitin Enzymes Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Ubiquitin Enzymes Revenue Market Share by Country (2015-2020)
Table 58. Latin America Ubiquitin Enzymes Sales by Type (2015-2020) (K Units)
Table 59. Latin America Ubiquitin Enzymes Sales Market Share by Type (2015-2020)
Table 60. Latin America Ubiquitin Enzymes Sales by Application (2015-2020) (K Units)
Table 61. Latin America Ubiquitin Enzymes Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Ubiquitin Enzymes Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Ubiquitin Enzymes Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Ubiquitin Enzymes Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Ubiquitin Enzymes Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Ubiquitin Enzymes Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Ubiquitin Enzymes Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Ubiquitin Enzymes Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Ubiquitin Enzymes Sales Market Share by Application (2015-2020)
Table 70. 3SBio Corporation Information
Table 71. 3SBio Description and Major Businesses
Table 72. 3SBio Ubiquitin Enzymes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. 3SBio Product
Table 74. 3SBio Recent Development
Table 75. 5AM Ventures Corporation Information
Table 76. 5AM Ventures Description and Major Businesses
Table 77. 5AM Ventures Ubiquitin Enzymes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. 5AM Ventures Product
Table 79. 5AM Ventures Recent Development
Table 80. Abbiotec Corporation Information
Table 81. Abbiotec Description and Major Businesses
Table 82. Abbiotec Ubiquitin Enzymes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Abbiotec Product
Table 84. Abbiotec Recent Development
Table 85. Abcam Corporation Information
Table 86. Abcam Description and Major Businesses
Table 87. Abcam Ubiquitin Enzymes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Abcam Product
Table 89. Abcam Recent Development
Table 90. AcelRx Pharmaceuticals Corporation Information
Table 91. AcelRx Pharmaceuticals Description and Major Businesses
Table 92. AcelRx Pharmaceuticals Ubiquitin Enzymes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. AcelRx Pharmaceuticals Product
Table 94. AcelRx Pharmaceuticals Recent Development
Table 95. Aegera Therapeutics Corporation Information
Table 96. Aegera Therapeutics Description and Major Businesses
Table 97. Aegera Therapeutics Ubiquitin Enzymes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Aegera Therapeutics Product
Table 99. Aegera Therapeutics Recent Development
Table 100. Aeneas Ventures Corporation Information
Table 101. Aeneas Ventures Description and Major Businesses
Table 102. Aeneas Ventures Ubiquitin Enzymes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Aeneas Ventures Product
Table 104. Aeneas Ventures Recent Development
Table 105. Agilis Biotherapeutics Corporation Information
Table 106. Agilis Biotherapeutics Description and Major Businesses
Table 107. Agilis Biotherapeutics Ubiquitin Enzymes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Agilis Biotherapeutics Product
Table 109. Agilis Biotherapeutics Recent Development
Table 110. Aileron Therapeutics Corporation Information
Table 111. Aileron Therapeutics Description and Major Businesses
Table 112. Aileron Therapeutics Ubiquitin Enzymes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Aileron Therapeutics Product
Table 114. Aileron Therapeutics Recent Development
Table 115. Aju IB Investment Corporation Information
Table 116. Aju IB Investment Description and Major Businesses
Table 117. Aju IB Investment Ubiquitin Enzymes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Aju IB Investment Product
Table 119. Aju IB Investment Recent Development
Table 120. Alexion Pharmaceuticals Corporation Information
Table 121. Alexion Pharmaceuticals Description and Major Businesses
Table 122. Alexion Pharmaceuticals Ubiquitin Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Alexion Pharmaceuticals Product
Table 124. Alexion Pharmaceuticals Recent Development
Table 125. Almac Discovery Corporation Information
Table 126. Almac Discovery Description and Major Businesses
Table 127. Almac Discovery Ubiquitin Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Almac Discovery Product
Table 129. Almac Discovery Recent Development
Table 130. Amgen Corporation Information
Table 131. Amgen Description and Major Businesses
Table 132. Amgen Ubiquitin Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Amgen Product
Table 134. Amgen Recent Development
Table 135. Angelman Syndrome Foundation Corporation Information
Table 136. Angelman Syndrome Foundation Description and Major Businesses
Table 137. Angelman Syndrome Foundation Ubiquitin Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Angelman Syndrome Foundation Product
Table 139. Angelman Syndrome Foundation Recent Development
Table 140. Apeiron Biologics Corporation Information
Table 141. Apeiron Biologics Description and Major Businesses
Table 142. Apeiron Biologics Ubiquitin Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Apeiron Biologics Product
Table 144. Apeiron Biologics Recent Development
Table 145. Boston Biochem Corporation Information
Table 146. Boston Biochem Description and Major Businesses
Table 147. Boston Biochem Ubiquitin Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Boston Biochem Product
Table 149. Boston Biochem Recent Development
Table 150. BPS Biosciences Corporation Information
Table 151. BPS Biosciences Description and Major Businesses
Table 152. BPS Biosciences Ubiquitin Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. BPS Biosciences Product
Table 154. BPS Biosciences Recent Development
Table 155. Business Development Bank of Canada Corporation Information
Table 156. Business Development Bank of Canada Description and Major Businesses
Table 157. Business Development Bank of Canada Ubiquitin Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. Business Development Bank of Canada Product
Table 159. Business Development Bank of Canada Recent Development
Table 160. C4 Therapeutics Corporation Information
Table 161. C4 Therapeutics Description and Major Businesses
Table 162. C4 Therapeutics Ubiquitin Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 163. C4 Therapeutics Product
Table 164. C4 Therapeutics Recent Development
Table 165. Calculus Capital Corporation Information
Table 166. Calculus Capital Description and Major Businesses
Table 167. Calculus Capital Ubiquitin Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 168. Calculus Capital Product
Table 169. Calculus Capital Recent Development
Table 170. Canaan Partners Corporation Information
Table 171. Canaan Partners Description and Major Businesses
Table 172. Canaan Partners Ubiquitin Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 173. Canaan Partners Product
Table 174. Canaan Partners Recent Development
Table 175. Cancer Research Technology Corporation Information
Table 176. Cancer Research Technology Description and Major Businesses
Table 177. Cancer Research Technology Ubiquitin Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 178. Cancer Research Technology Product
Table 179. Cancer Research Technology Recent Development
Table 180. Captor Therapeutics Corporation Information
Table 181. Captor Therapeutics Description and Major Businesses
Table 182. Captor Therapeutics Ubiquitin Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 183. Captor Therapeutics Product
Table 184. Captor Therapeutics Recent Development
Table 185. Carmot Therapeutics Corporation Information
Table 186. Carmot Therapeutics Description and Major Businesses
Table 187. Carmot Therapeutics Ubiquitin Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 188. Carmot Therapeutics Product
Table 189. Carmot Therapeutics Recent Development
Table 190. Cayman Chemicals Corporation Information
Table 191. Cayman Chemicals Description and Major Businesses
Table 192. Cayman Chemicals Ubiquitin Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 193. Cayman Chemicals Product
Table 194. Cayman Chemicals Recent Development
Table 195. Celgene Corporation Corporation Information
Table 196. Celgene Corporation Description and Major Businesses
Table 197. Celgene Corporation Ubiquitin Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 198. Celgene Corporation Product
Table 199. Celgene Corporation Recent Development
Table 200. Cell Signaling Technology Corporation Information
Table 201. Cell Signaling Technology Description and Major Businesses
Table 202. Cell Signaling Technology Ubiquitin Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 203. Cell Signaling Technology Product
Table 204. Cell Signaling Technology Recent Development
Table 205. Global Ubiquitin Enzymes Sales Forecast by Regions (2021-2026) (K Units)
Table 206. Global Ubiquitin Enzymes Sales Market Share Forecast by Regions (2021-2026)
Table 207. Global Ubiquitin Enzymes Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 208. Global Ubiquitin Enzymes Revenue Market Share Forecast by Regions (2021-2026)
Table 209. North America: Ubiquitin Enzymes Sales Forecast by Country (2021-2026) (K Units)
Table 210. North America: Ubiquitin Enzymes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 211. Europe: Ubiquitin Enzymes Sales Forecast by Country (2021-2026) (K Units)
Table 212. Europe: Ubiquitin Enzymes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 213. Asia Pacific: Ubiquitin Enzymes Sales Forecast by Region (2021-2026) (K Units)
Table 214. Asia Pacific: Ubiquitin Enzymes Revenue Forecast by Region (2021-2026) (US$ Million)
Table 215. Latin America: Ubiquitin Enzymes Sales Forecast by Country (2021-2026) (K Units)
Table 216. Latin America: Ubiquitin Enzymes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 217. Middle East and Africa: Ubiquitin Enzymes Sales Forecast by Country (2021-2026) (K Units)
Table 218. Middle East and Africa: Ubiquitin Enzymes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 219. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 220. Key Challenges
Table 221. Market Risks
Table 222. Main Points Interviewed from Key Ubiquitin Enzymes Players
Table 223. Ubiquitin Enzymes Customers List
Table 224. Ubiquitin Enzymes Distributors List
Table 225. Research Programs/Design for This Report
Table 226. Key Data Information from Secondary Sources
Table 227. Key Data Information from Primary Sources
List of Figures
Figure 1. Ubiquitin Enzymes Product Picture
Figure 2. Global Ubiquitin Enzymes Sales Market Share by Type in 2020 & 2026
Figure 3. E1 Ubiquitin Activating Enzyme Product Picture
Figure 4. E2 Ubiquitin Crosslinking Enzyme Product Picture
Figure 5. E3 Ubiquitin Ligase Product Picture
Figure 6. Global Ubiquitin Enzymes Sales Market Share by Application in 2020 & 2026
Figure 7. Cancer
Figure 8. Biological Engineering
Figure 9. Gastroenterology
Figure 10. Others
Figure 11. Ubiquitin Enzymes Report Years Considered
Figure 12. Global Ubiquitin Enzymes Market Size 2015-2026 (US$ Million)
Figure 13. Global Ubiquitin Enzymes Sales 2015-2026 (K Units)
Figure 14. Global Ubiquitin Enzymes Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Ubiquitin Enzymes Sales Market Share by Region (2015-2020)
Figure 16. Global Ubiquitin Enzymes Sales Market Share by Region in 2019
Figure 17. Global Ubiquitin Enzymes Revenue Market Share by Region (2015-2020)
Figure 18. Global Ubiquitin Enzymes Revenue Market Share by Region in 2019
Figure 19. Global Ubiquitin Enzymes Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Ubiquitin Enzymes Revenue in 2019
Figure 21. Ubiquitin Enzymes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Ubiquitin Enzymes Sales Market Share by Type (2015-2020)
Figure 23. Global Ubiquitin Enzymes Sales Market Share by Type in 2019
Figure 24. Global Ubiquitin Enzymes Revenue Market Share by Type (2015-2020)
Figure 25. Global Ubiquitin Enzymes Revenue Market Share by Type in 2019
Figure 26. Global Ubiquitin Enzymes Market Share by Price Range (2015-2020)
Figure 27. Global Ubiquitin Enzymes Sales Market Share by Application (2015-2020)
Figure 28. Global Ubiquitin Enzymes Sales Market Share by Application in 2019
Figure 29. Global Ubiquitin Enzymes Revenue Market Share by Application (2015-2020)
Figure 30. Global Ubiquitin Enzymes Revenue Market Share by Application in 2019
Figure 31. North America Ubiquitin Enzymes Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Ubiquitin Enzymes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Ubiquitin Enzymes Sales Market Share by Country in 2019
Figure 34. North America Ubiquitin Enzymes Revenue Market Share by Country in 2019
Figure 35. U.S. Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Ubiquitin Enzymes Market Share by Type in 2019
Figure 40. North America Ubiquitin Enzymes Market Share by Application in 2019
Figure 41. Europe Ubiquitin Enzymes Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Ubiquitin Enzymes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Ubiquitin Enzymes Sales Market Share by Country in 2019
Figure 44. Europe Ubiquitin Enzymes Revenue Market Share by Country in 2019
Figure 45. Germany Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Ubiquitin Enzymes Market Share by Type in 2019
Figure 56. Europe Ubiquitin Enzymes Market Share by Application in 2019
Figure 57. Asia Pacific Ubiquitin Enzymes Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Ubiquitin Enzymes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Ubiquitin Enzymes Sales Market Share by Region in 2019
Figure 60. Asia Pacific Ubiquitin Enzymes Revenue Market Share by Region in 2019
Figure 61. China Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Ubiquitin Enzymes Market Share by Type in 2019
Figure 84. Asia Pacific Ubiquitin Enzymes Market Share by Application in 2019
Figure 85. Latin America Ubiquitin Enzymes Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Ubiquitin Enzymes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Ubiquitin Enzymes Sales Market Share by Country in 2019
Figure 88. Latin America Ubiquitin Enzymes Revenue Market Share by Country in 2019
Figure 89. Mexico Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Ubiquitin Enzymes Market Share by Type in 2019
Figure 96. Latin America Ubiquitin Enzymes Market Share by Application in 2019
Figure 97. Middle East and Africa Ubiquitin Enzymes Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Ubiquitin Enzymes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Ubiquitin Enzymes Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Ubiquitin Enzymes Revenue Market Share by Country in 2019
Figure 101. Turkey Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. UAE Ubiquitin Enzymes Sales Growth Rate (2015-2020) (K Units)
Figure 106. UAE Ubiquitin Enzymes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Ubiquitin Enzymes Market Share by Type in 2019
Figure 108. Middle East and Africa Ubiquitin Enzymes Market Share by Application in 2019
Figure 109. North America Ubiquitin Enzymes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America Ubiquitin Enzymes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Ubiquitin Enzymes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe Ubiquitin Enzymes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Ubiquitin Enzymes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific Ubiquitin Enzymes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Ubiquitin Enzymes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America Ubiquitin Enzymes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Ubiquitin Enzymes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa Ubiquitin Enzymes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
ユビキチンプロテアソームの世界市場（～2026年） Market Analysis and Insights: Global Ubiquitin Proteasome Market The global Ubiquitin Proteasome market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ubiquitin Proteasome Scope and Market Size Ubiquitin Proteasome market is…- E3ユビキチンタンパク質リガーゼXIAPの世界市場（～2026年） Market Analysis and Insights: Global E3 Ubiquitin Protein Ligase XIAP Market The global E3 Ubiquitin Protein Ligase XIAP market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global E3 Ubiquitin Protein Ligase XIAP Scope and Market…
- バイオ燃料における酵素の世界市場（～2026年） Market Analysis and Insights: Global Enzymes in Biofuel Market The global Enzymes in Biofuel market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Enzymes in Biofuel Scope and Market Size Enzymes in Biofuel market is segment…
- ベーキング酵素の世界市場（～2026年） Market Analysis and Insights: Global Baking Enzymes Market The global Baking Enzymes market size is projected to reach US$ 664.4 million by 2026, from US$ 632 million in 2020, at a CAGR of 4.9%% during 2021-2026. Global Baking Enzymes Scope and Market Size Baking Enzymes market is segmented by Type,…
- アルコール酵素の世界市場（～2026年） Alcohol enzymes is an enzyme group that occurs in organisms to facilitate hydrolysis and ease the inter conversion between alcohol and aldehydes due to the reduction of nicotinamide adenine dinucleotide. They are used as catalysts in the process of conversion of complex molecules in different metabo…